This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,561.98 firm fixed-price contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a period of performance through November 15, 2024.
The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award did not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems.
Generated 2/13/25, 9:03 AM